X hits on this document

Word document

ПРОТОКОЛ ВЕДЕНИЯ БОЛЬНЫХ - page 217 / 220

1083 views

0 shares

0 downloads

0 comments

217 / 220

18.

Яхно Н.Н., Хатиашвили И.Т. Паркинсонизм: клиника, диагноз и дифференциальный диагноз.// Русский Медицинский журнал. 2002, том 8, №10, с.418-425.

19.

Aarsland D., Larsen J.P., Lim N.G. et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease.// J.Neurol., 1999. -V.67. -P.492-496.

20.

Ahlskog JG, Cornelia CL, Hubble JP, et al. Early Parkinson's disease. Neurology 1994 Dec: 44 Suppl. 10: S.9-52

21.

Albanese A, Bonuccelli U, Brefel C, et al. Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.// Mov. Disord., 2001.-V.-16.-P.197-201.

22.

Bejjani B, Damier P, Arnulf I, et al: Pallidal stimulation for Parkinson's disease. Neurology 49:1564, 1997  

23.

Bhatia K, Brooks D, Burn D, et al. Guidelines for the management of Parkinson's disease. Hospital Medicine 1998;59:469–80.

24.

Brooks D.J. The early diagnosis of Parkinson's disease//Ann Neurol 1998;44(Suppl 1):S10-S18.

25.

Clarke C E, Speller J M, Clarke J A. Pramipexole for levodopa-induced complications in Parkinson's disease (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.

26.

Clarke CE, Davies P. Systemic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease.// J. Neurol. Neurosurg. Psychiatry,2000.-V.69.-P.590-594.

27.

Clarke CE. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.// Mov. Disord., 1995.-V.10(No. 3).-P.250-256.

28.

Clarkson ED, Freed CR: Development of fetal neuronal transplantation as a treatment for Parkinson's disease. Life Sci 65:2427, 1999  

29.

Crosby N J, K H O Deane, C E Clarke. Amantadine for dyskinesia in Parkinson's disease (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software

30.

Deane K H O, Jones D, Playford E D, Ben-Shlomo Y, Clarke C E.. Physiotherapy versus placebo or no intervention in Parkinson's disease (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.

31.

Dubois B., Pillon B. Cognitive and behavioral aspects of movement disorders // In: J.Jankovic, E.Tolosa (eds). Parkinson's disease and movement disorders. 3nd ed. – Baltimore. Williams&Wilkins, 1998. -P.837-858.

32.

Fahn S: Medical treatment of Parkinson's disease. J Neurol 245:15, 1998   Fernandez HH, Lapane KL. Does selegiline increase mortality among Parkinson patients in long-term care? Ann Neurol 2000; 48: 433. Abstract.  

33.

FitzGerald P.M., Jankovic J. Lower body parkinsonism: evidence for vascular etiology.// Mov.Disord., 1989. – V.4. – P. 249-260.

Document info
Document views1083
Page views1083
Page last viewedMon Dec 05 00:25:28 UTC 2016
Pages220
Paragraphs3090
Words41635

Comments